Celltrion | 068270 - Operating Expenses

Stock Price
188,800.00
Daily Change
-6,300.00 -3.23%
Monthly
-9.67%
Yearly
22.60%
Q2 Forecast
177,698.56

Celltrion reported KRW140.68B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Celltrion KRW 140.68B 584.31B Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Ionis Pharmaceuticals USD 364M 54M Mar/2026
IQVIA Holdings USD 6.22B 4.53B Mar/2026
Moderna USD 1.78B 242M Mar/2026
Organon & Co USD 903M 387M Mar/2026
Revvity USD 628.34M 2.12M Mar/2026
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Viatris USD 3.54B 323.9M Mar/2026
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025